Scarica l'app Stockscreener
6.195
1.72%
0.095
Precedente Chiudi:
$6.10
Aprire:
$6.14
Volume 24 ore:
1.25M
Relative Volume:
0.44
Capitalizzazione di mercato:
$985.87M
Reddito:
$418.84M
Utile/perdita netta:
$-1.60M
Rapporto P/E:
-601.46
EPS:
-0.0103
Flusso di cassa netto:
$69.77M
1 W Prestazione:
-2.74%
1M Prestazione:
-8.75%
6M Prestazione:
-47.42%
1 anno Prestazione:
-38.87%
Intervallo 1D:
$6.11
$6.30
Intervallo di 1 settimana:
$6.02
$6.42
Portata 52W:
$6.02
$15.38
Certara Inc Stock (CERT) Company Profile
Nome
Certara Inc
Settore
Industria
Telefono
(415) 237-8272
Indirizzo
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
6.195 | 970.75M | 418.84M | -1.60M | 69.77M | -0.0103 |
VEEV
Veeva Systems Inc
|
181.06 | 29.09B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.72 | 8.61B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.52 | 8.36B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
84.16 | 6.97B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.75 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Overweight → Equal Weight |
| 2026-02-27 | Downgrade | Craig Hallum | Buy → Hold |
| 2026-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-09-29 | Iniziato | Craig Hallum | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-09-27 | Aggiornamento | UBS | Neutral → Buy |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Perform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-10 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-04-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Iniziato | Berenberg | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-01 | Iniziato | Piper Sandler | Overweight |
| 2022-01-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-23 | Iniziato | Robert W. Baird | Outperform |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Iniziato | BofA Securities | Buy |
| 2021-01-05 | Iniziato | Credit Suisse | Neutral |
| 2021-01-05 | Iniziato | Jefferies | Hold |
| 2021-01-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Certara Inc Borsa (CERT) Ultime notizie
When Will Certara, Inc. (NASDAQ:CERT) Become Profitable? - 富途牛牛
If You Invested $1,000 in Certara, Inc. (CERT) - Stock Titan
Certara (NASDAQ:CERT) Sets New 1-Year LowHere's Why - MarketBeat
Understanding Momentum Shifts in (CERT) - Stock Traders Daily
Sentiment Review: Is Certara Inc being accumulated by smart moneyMarket Activity Recap & Daily Profit Focused Stock Screening - baoquankhu1.vn
Buy Signal: Whats the RSI of Certara Inc stock2026 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
Certara, Inc. $CERT Stock Position Boosted by Kopion Asset Management LLC - MarketBeat
Market Wrap: Can Certara Inc lead its sector in growthWeekly Profit Recap & High Yield Equity Trading Tips - baoquankhu1.vn
CERT SEC FilingsCertara, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches - simplywall.st
Certara, Inc. $CERT is ArrowMark Colorado Holdings LLC's 5th Largest Position - MarketBeat
Is Certara (CERT) Offering Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Topline Capital Management LLC Purchases Shares of 546,471 Certara, Inc. $CERT - MarketBeat
Brown Brothers Harriman & Co. Has $46 Million Holdings in Certara, Inc. $CERT - MarketBeat
Alpha Wave Global LP Takes Position in Certara, Inc. $CERT - MarketBeat
Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip - MarketBeat
Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds - MarketBeat
Certara (CERT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Avoiding Lag: Real-Time Signals in (CERT) Movement - Stock Traders Daily
Certara at Barclays Healthcare Conference: Strategic Growth and AI Integration - Investing.com South Africa
Dixon Mitchell Investment Counsel Inc. Purchases Shares of 866,380 Certara, Inc. $CERT - MarketBeat
Certara at Leerink Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com South Africa
Certara at Leerink Conference: Strategic Moves Amid Challenges - Investing.com
Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
How Investors Are Reacting To Certara (CERT) FDA Acceptance Of Simcyp In Place Of Clinical Trials - simplywall.st
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And Latest Earnings Guidance - Sahm
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference - Yahoo Finance
Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook - MSN
Earnings estimates moving higher for Certara (CERT): Time to buy? - MSN
Will Certara Inc. stock outperform international peers2025 EndofYear Setup & Short-Term Trading Alerts - Naître et grandir
CERTCertara Inc Stock Price and Quote - Finviz
Certara, Inc. (CERT): Analysts Assign Equal-Weight Rating Amid Price Stagnation - 富途牛牛
Certara (CERT) Downgraded to Equal-Weight by Barclays | CERT Sto - GuruFocus
Certara's (CERT) Equal Weight Rating Reiterated at Barclays - MarketBeat
Forecasting The Future: 7 Analyst Projections For Certara - Benzinga
Barclays downgrades Certara stock rating on turnaround concerns By Investing.com - Investing.com South Africa
Barclays downgrades Certara stock rating on turnaround concerns - Investing.com
Certara at TD Cowen Conference: Strategic Focus and AI Integration By Investing.com - Investing.com Canada
Certara at TD Cowen Conference: Strategic Focus and AI Integration - Investing.com UK
Certara (CERT) Gains FDA Acceptance for PBPK Modeling in Drug Ap - GuruFocus
Certara, Inc. (CERT) Stock Analysis: Exploring a 38% Potential Upside in Health Information Services - DirectorsTalk Interviews
CERT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Certara Simcyp® simulator results replace ten human trials for chronic myeloid leukemia (CML) therapy asciminib - marketscreener.com
Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - Bitget
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - The Manila Times
FDA accepts virtual-patient data so leukemia drug avoids 10 trials - Stock Titan
Certara, Inc. $CERT Stock Holdings Boosted by Roubaix Capital LLC - MarketBeat
Certara Earnings Call: Software Strength Amid Transition - The Globe and Mail
Certara (CERT) director granted 5,547 restricted stock units - Stock Titan
Certara (CERT) director Arjun Bedi submits initial Form 3 insider filing - Stock Titan
Certara Inc Azioni (CERT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.41%
3.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):